Skip to search.
 STI Down 1.77%
Streaming
Ticker Tape: On

Forest Laboratories Inc. (FRX)

-NYSE

39.08 Up 1.57(4.19%) 02:51 SGT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:37.51
Open:38.01
Bid:38.83 x 700
Ask:38.84 x 2100
1y Target Est:38.29
Beta:0.55
Next Earnings Date:N/A
Day's Range:38.01 - 39.09
52wk Range:31.28 - 39.09
Volume:2,677,188
Avg Vol (3m):1,313,060
Market Cap:10.41B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FRXUp 4.19%10.41B
NVODown 0.54%91.71B
TEVAUp 0.71%33.87B
AGNDown 0.23%28.98B

Key Statistics

Forward P/E (1 yr):24.90
P/S (ttm):3.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-14) :0.88
Quarterly EPS Est (Jun-13) :0.11
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products primarily in the United States and Europe. It principally offers Namenda for the treatment of moderate and severe Alzheimer's disease; Bystolic... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback